A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome
暂无分享,去创建一个
E. Lippert | J. Amiral | J. Ianotto | F. Mingant | H. Galinat | C. Hoffmann | H. Kerspern | H. Jantzem | B. Pan Petesch | S. Rézig | Sara Robin | Adam Collins | C. Mornet
[1] G. Lippi,et al. Acquired factor V inhibitors: a systematic review , 2011, Journal of Thrombosis and Thrombolysis.
[2] D. Peetz,et al. Massive Blutungsneigung bei zwei Patienten mit Faktor-V-Hemmkörper und Anti-Phospholipid-Antikörpern nach Ciprofloxacin-Einnahme , 2003, Medizinische Klinik.
[3] J. Zehnder,et al. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. , 1990, Blood.
[4] H. Glueck,et al. Hemorrhagic death associated with a high titer factor V inhibitor , 1978, American journal of hematology.
[5] S. Stenbjerg,et al. A circulating factor V inhibitor: possible side effect of treatment with streptomycin. , 2009, Scandinavian journal of haematology.